Octave Specialty (OSG) EBT (2010 - 2026)

Octave Specialty's EBT history runs 17 years deep, the most recent figure standing at -$3.3 million for Q1 2026.

• On a quarterly basis, EBT rose 77.86% year-over-year to -$3.3 million in Q1 2026; TTM through Mar 2026 was -$89.3 million, a 24.46% decrease from a year earlier, with the FY2025 full-year figure at -$101.0 million, down 68.79% from the prior year.
• EBT advanced to -$3.3 million in Q1 2026 per OSG's latest filing, from -$30.9 million in the prior quarter.
• Across five years, EBT topped out at $342.0 million in Q3 2022 and bottomed at -$387.7 million in Q4 2022.
• The 5-year median for EBT is -$15.1 million (2025), against an average of -$13.2 million.
• Biggest YoY gain for EBT was 1700.0% in 2022; the steepest drop was 1940.56% in 2022.
• Year by year, EBT stood at -$387.7 million in 2022, then jumped by 86.53% to -$52.2 million in 2023, then soared by 59.59% to -$21.1 million in 2024, then plunged by 46.23% to -$30.9 million in 2025, then jumped by 89.16% to -$3.3 million in 2026.
• Per Business Quant, the three latest OSG EBT figures stand at -$3.3 million (Q1 2026), -$30.9 million (Q4 2025), and -$32.1 million (Q3 2025).